Isaac Mackenzie

Cabotegravir and Rilpivirine Long-Acting Antiretroviral Therapy Administered Every 2 Months is Cost-Effective for the Treatment of HIV-1 in Spain

V. Falcó, A. Rivero, S. Moreno, 2023, Infectious Diseases and Therapy.